REVIEW ARTICLES
Pain in head and neck cancer: prevalence and possible predictive factors
Chiara Bianchini, Francesco Maldotti, Laura Crema, Mariasole Malagò, Andrea Ciorba; pp 592-597 (Pubmed Abstract, PDF )
The role of cytoreductive surgery in advanced ovarian cancer: the general surgeon’s perspective
Konstantinos Romanidis, Eleni-Aikaterini Nagorni, Evgenia Halkia, Michael Pitiakoudis; pp 598-604 (Pubmed Abstract, PDF )
Proximal shift of colorectal cancer. A persistent phenomenon with multiple causes, patterns and
clinical implications
Petros C. Papagiorgis, Ioannis Oikonomakis, Dionysios Delaportas, Despoina Myoteri, Elissavet Arkoumani,
Nikolaos Thalassinos, Adamantia Zizi-Sermpetzoglou; pp 605-617 (Pubmed Abstract, PDF )
Management of peritoneal surface malignancy: a review of the recent literature
Evgenia Halkia, Stylianos Gavriel, John Spiliotis; pp 618-626 (Pubmed Abstract, PDF )
ORIGINAL ARTICLES
BREAST CANCER
The effects of hypericin on ADAMTS and p53 gene expression in MCF-7 breast cancer cells
Muradiye Acar, Zeynep Ocak, Kubra Erdogan, Elif Nihan Cetin, Omer Faruk Hatipoglu, Ummugul Uyeturk, Esra Gunduz, Mehmet Gunduz; pp 627-632 (Pubmed Abstract, PDF )
Association of FokI and PvuII polymorphisms with breast cancer staging and survival among Caucasian women: A prospective study
Anneza I. Yiallourou, Emmanouel Ekonomou, Vassilios Tsamadias, Konstantinos Nastos, Konstantinos Karapanos, Ioannis Papaconstantinou, Theodosios Theodosopoulos, John Contis, Efstathios Papalambros, Dionysios Voros, John Psychogios; pp 633-642 (Pubmed Abstract, PDF )
Three-dimensional ultrasonography for the prediction of breast cancer prognosis
Guang Xu, Ting Han, Ming-Hua Yao, Juan Xie, Hui-Xiong Xu, Rong Wu; pp 643-649 (Pubmed Abstract, PDF )
Emodin azide methyl anthraquinone derivative induced G0/G1 arrest in HER2/neu-overexpressing MDA-MB-453 breast cancer cells
Yan-yan Yan, Li-wu Fu, Wei Zhang, Hong-shan Ma, Cun-gen Ma, Yong-ju Liang, Bin-yu Liu, Jie-zhong
Yu, Qiu-zhen Wu, Yi-min Dong; pp 650-655 (Pubmed Abstract, PDF )
Knockdown of CETN1 inhibits breast cancer cells proliferation
Xu Shuangta, He Yali, Zheng Zhengrong, Zhao Qingquan, Zeng Xiaoshan, Yao fanghui, Waihung Ng, Liang yinghui, Xu Jianhua; pp 656-661 (Pubmed Abstract, PDF )
Comparison of clinical characteristics between occult and non-occult breast cancer
Sun Ping, Wang H Ming, Shen H Bin, Wu D Wen, Qian Cheng, Chen C Jun, Hu Y Bin, Cao Z Jian; pp 662-666 (Pubmed Abstract, PDF)
GSPECT-CT myocardial scintigraphy plus calcium scores as screening tool for prevention of cardiac side effects in left-sided breast cancer radiotherapy
Antonia Tzonevska, Anna Chakarova, Krasimir Tzvetkov; pp 667-672 (Pubmed Abstract, PDF)
Impact of inflammatory markers on the prognosis of patients with operable breast cancer
Ibrahim Petekkaya, Sercan Aksoy, Emir C. Roach, Alexis K Okoh, Gizen Gecmez, Gamze Gezgen, Deniz C Isler, Erkan Dogan, Taner Babacan, Furkan Sarici, Emine Petekkaya, Kadri Altundag; pp 673-680 (Pubmed Abstract, PDF )
COLORECTAL CANCER
Post-treatment plasma omentin levels in patients with stage III colon carcinoma
Ummugul Uyeturk, Aytekin Alcelik, Gulali Aktas, Buket Kin Tekce; pp 681-685 (Pubmed Abstract, PDF )
Prognostic role of Aurora-A expression in metastatic colorectal cancer patients
Sevil Goktas, Mustafa Yildirim, Dinc Suren, Arsenal Sezgin Alikanoglu, Utku Donem Dilli, Nurullan Bulbuller, Cem Sezer, Mustafa Yildiz; pp 686-691 (Pubmed Abstract, PDF )
HEPATOCELLULAR CANCER
Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma
Wen-Jun Chen, Shao-Fei Yuan, Lin-Jia Zhu, Xiao-Nan Sun, Weie Zheng; pp 692-697 (Pubmed Abstract, PDF )
Effects and mechanism of suberoylanilide hydroxamic acid on the proliferation and apoptosis of human hepatoma cell line Bel-7402
Yingchun Wang, Wei-Zong Kong, Lan-Hua Xing, Xu Yang; pp 698-704 (Pubmed Abstract, PDF )
The antitumor effect and mechanism of taipeinine A, a new C19-diterpenoid alkaloid from Aconitum taipeicum, on the HepG2 human hepatocellular carcinoma cell line
Hui Zhang, Zengjun Guo, Ling Han, Xiaojuan You, Ying Xu; pp 705-712 (Pubmed Abstract, PDF )
GASTRIC CANCER
Effects of resveratrol on the protein expression of survivin and cell apoptosis in human gastric cancer cells
Min Li Liu, Sheng Jun Zhang; pp 713-717 (Pubmed Abstract, PDF )
CNS CANCER
Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide
Evangelia Peponi, Ioannis Tourkantonis, Ifigeneia Tasiou, Nicholas Pavlidis, George Pentheroudakis, Periklis Tsekeris; pp 718-723 (Pubmed Abstract, PDF )
Characteristics of childhood glial tumors, management approaches and life expectancy of the patients
Alaettin Arslan, Yildiz Guney, Yasemin Benderli Cihan, Mehmet Faik Cetindag; pp 724-732 (Pubmed Abstract, PDF )
Effects of TNFα on cell viability, proliferation and apoptosis of glioma cells U251
Zhang Peng, Lu Ying; pp 733-741 (Pubmed Abstract, PDF )
LUNG CANCER
Osteopontin expression is associated with platinum-based chemotherapy response and prognosis of patients with advanced non small cell lung cancer
Tao Zhang, Dong-ming Zhang, Da Zhao, Xiao-ming Hou, Tian-ning Yang; pp 742-748 (Pubmed Abstract, PDF )
Do trace element levels have prognostic value in non-small cell lung cancer patients treated with chemoradiotherapy?
Yasemin Benderli Cihan; pp 749-756 (Pubmed Abstract, PDF)
Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis
Xin Zhao, Yan Yuan, Zhiqiang Zhang, Xianjun Feng, Jian Zhang, Xiaomei Yuan, Jinlan Li; pp 757-762 (Pubmed Abstract, PDF )
PROSTATE CANCER
A hypofractionated radiotherapy schedule with 57.75Gy in 21 fractions for T1-2N0 prostate carcinoma: Analysis of late toxicity and efficacy
Vassilis Kouloulias, Anna Zygogianni, Ioanna Kantzou, Maria Tolia1, Kalliopi Platoni, Christos Antypas, Demetrios Chaldeopoulos, Panagiotis Pantelakos, Argyrios Siatelis, Michael Chrysofos, Ivelina Beli, Maria Dilvoi, Ioannis Georgakopoulos, George Sarris, John Kouvaris, Nikolaos Kelekis; pp 763-769 (Pubmed Abstract, PDF )
Regulatory roles of KDR antisense oligonucleotide on the proliferation of human prostate cancer cell line PC-3
Jianghong Song, Yisheng Song, Wei Guo, Junqi Jia, Yongsheng Jin, Ansheng Bai; pp 770-774 (Pubmed Abstract, PDF )
TESTICULAR CANCER
Is there an intermediate-risk non-seminoma? Long-term treatment results from a single center
Jakub Cvek, David Feltl, Jaroslav Hajek, Jana Jackaninova, Klara Ruzickova, Ondrej Havranek, Jana Dvorackova, Premysl Dobes; pp 775-779 (Pubmed Abstract, PDF )
SKIN CANCER
Expression of vascular endothelial growth factor and microvascular density assessment in different histotypes of basal cell carcinoma
Milena S. Vuletic, Snezana A. Jancic, Milena B. Ilic, Goran LJ. Azanjac, Ivana S. Joksimovic, Sanja M. Milenkovic, Mirjana A. Janicijevic-Petrovic, Vesna D. Stankovic; pp 780-786 (Pubmed Abstract, PDF )
HEMATOLOGIC MALIGNANCIES
Association of -174G/C interleukin-6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients
Pelin Mutlu, Serap Yalcin, Pinar Elci, Murat Yildirim, A. Turker Cetin, Ferit Avcu; pp 787-791 (Pubmed Abstract, PDF)
PSYCHOONCOLOGY
Locus of control and distressing symptoms in young cancer patients when assessing depression
I. Panagiotou, E. Tsilika, E. Parpa, E. Patiraki, A. Zygogianni, V. Kouloulias, K. Mystakidou; pp 792-798 (Pubmed Abstract, PDF)
Types of reactions to malignant disease in view of V.E. Frankl philosophy
Mikołaj Majkowicz, Piotr Pankiewicz, Agata Zdun-Ryżewska, Magdalena Z. Podolska; pp 799-806 (Pubmed Abstract, PDF)
Continuous distress in an Oncology Clinic in Turkey: Should we make use of the distress thermometer mandatory as a precautionary measure for physicians?
Ahmet Taner Sumbul, Ahmet Sezer, Huseyin Abali, Umut Dicel, Ilhami Gultepe, Ali Ayberk Besen, Ozgur Ozyilkan; pp 807-811 (Pubmed Abstract, PDF)
SYMPTOM PALLIATION
Aggressive interventions in terminally ill patients with solid tumors in China: a retrospective single center analysis
Chen Xin Deng, Xiao Hong Liu, Hua Qin Xie, Jia Yuan, Tian Lin Xiao, Yue Hua Wang, Tie Nan Yi; pp 812-818 (Pubmed Abstract, PDF )
Radiotherapy combined with daily escitalopram in patients with painful bone metastasis: clinical evaluation and quality of life measurements
Maria Tolia, Andreas Fotineas, Kalliopi Nikolaou, Emmanouil Rizos, Ioanna Kantzou, Anna Zygogianni, John Kouvaris, Kalliopi Platoni, Panagiotis Pantelakos, George Sarris, Nikolaos Kelekis, Vassilis Kouloulias; pp 819-825 (Pubmed Abstract, PDF )
Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain
Lixia Huang, Fan Tao, Zhen Wang, Haifang Wan, Pisheng Qu, Hanguang Zheng; pp 826-830 (Pubmed Abstract, PDF )
MISCELLANEOUS
Role of SPECT-CT in radiotherapy
Sonya Sergieva, Iglika Mihailova, Zahary Zahariev, Milena Dimcheva, Stanislav Bozhikov; pp 831-835 (Pubmed Abstract, PDF )
False positive PET scan deserves attention
Asli Gul Akgul, Serife Tuba Liman, Salih Topcu, Mustafa Yuksel; pp 836-841 (Pubmed Abstract, PDF )
Totally implantable central venous catheters of the port-a-cath type: complications due to its use in the treatment of cancer patients
Miroslav Granic, Darko Zdravkovic, Sandra Krstajic, Sanja Kostic, Aleksandar Simic, Momir Sarac, Nebojsa Ivanovic, Dragan Radovanovic, Srdjan Dikic, Vladimir Kovcin; pp 842-846 (Pubmed Abstract, PDF )
Association of LEPR K109R polymorphisms with cancer risk: A systematic review and pooled analysis
Hui Shi, Hexi Shu, Changjia Huang, Jinpeng Gong, Yunji Yang, Run Liu, Yong Yang, Pengcheng Liu; pp 847-854 (Pubmed Abstract, PDF )
Lack of association between LEPR Q223R polymorphisms and cancer susceptibility: Evidence from a meta-analysis
Pengcheng Liu, Hui Shi, Run Liu, Yunji Yang, Yong Yang, Changjia Huang, Hexi Shu, Jinpeng Gong, Ming Cai; pp 855-862 (Pubmed Abstract, PDF )
LETTERS TO THE EDITOR
The emerging antineoplastic effects of nitidine chloride
Ji-Liang Xu, Rong Xia; p 863 (Pubmed Abstract, PDF )
Recurrent parathyroid carcinoma with spinal metastases unresponsive to cinacalcet therapy
Mehmet A.N. Sendur, Selcuk Dagdelen, Osman Abbasoglu, Belkis Erbas, Cenk Sokmensuer, Ibrahim Ziyal, Tomris Erbas; pp 863-864 (Pubmed Abstract, PDF )
Does cetuximab cause small bowel perforation?
Mehmet Akif Ozturk, Orhan Onder Eren, Basak Oyan; p 865 (Pubmed Abstract, PDF)
HISTORY OF ONCOLOGY
Otto Hahn (1879-1968): pioneer in radiochemistry and discoverer of radiotherapeutic mesothorium
Markos Sgantzos, George Kyrgias, Panagiotis Georgoulias, Marianna Karamanou, Gregory Tsoucalas, George Androutsos; pp 866-869 (Pubmed Abstract, PDF)
